Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - thelancet.com
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …
in their molecular landscapes. In this systematic review, we consolidated all existing …
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …
in their molecular landscapes. In this systematic review, we consolidated all existing …
[PDF][PDF] Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - aura.abdn.ac.uk
First Author: Subarnarekha Chatterji, MSc Order of Authors: Subarnarekha Chatterji, MSc
Emma Krzoska, MChem Christopher Thoroughgood, PhD John Saganty, MPhil Peng Liu …
Emma Krzoska, MChem Christopher Thoroughgood, PhD John Saganty, MPhil Peng Liu …
[PDF][PDF] Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska, CW Thoroughgood, J Saganty… - Lancet Oncol, 2023 - binasss.sa.cr
Breast cancer affects both sexes but is around 100 times rarer in men. 1 Statistics from 2019
show that 25 143 men were affected worldwide, with a 48· 1% mortality rate. 2 In …
show that 25 143 men were affected worldwide, with a 48· 1% mortality rate. 2 In …
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - europepmc.org
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …
in their molecular landscapes. In this systematic review, we consolidated all existing …
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - Elsevier
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …
in their molecular landscapes. In this systematic review, we consolidated all existing …
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
S Chatterji, E Krzoska, CW Thoroughgood… - The Lancet …, 2023 - abdn.elsevierpure.com
While similar phenotypically, there is evidence that male and female breast cancer differ in
their molecular landscapes. In this systematic review, we consolidated all existing prognostic …
their molecular landscapes. In this systematic review, we consolidated all existing prognostic …